Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria.
about
Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malariaOpsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.Watch out for malaria: still a leading cause of child death worldwide.Identifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts.Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes.Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytesHigh yield purification of Plasmodium falciparum merozoites for use in opsonizing antibody assays.Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoitesThe impact of lipid-based nutrient supplementation on anti-malarial antibodies in pregnant women in a randomized controlled trial.Malaria and immunity during pregnancy and postpartum: a tale of two speciesThe Impact of HIV Coinfection on Cerebral Malaria Pathogenesis.Imported malaria including HIV and pregnant woman risk groups: overview of the case of a Spanish city 2004-2014.Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.Malaria during Pregnancy.HIV and co-infections.A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.Peripheral blood mononuclear cells derived from grand multigravidae display a distinct cytokine profile in response to P. falciparum infected erythrocytes.HIV and malaria interactions: where do we stand?HIV-1 infection and antibodies to Plasmodium falciparum in adults.Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report.The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria.Patterns of protective associations differ for antibodies to P.falciparum-infected erythrocytes and merozoites in immunity against malaria in children.A versatile, high through-put, bead-based phagocytosis assay for Plasmodium falciparum.Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancy.
P2860
Q30603697-7DA3C374-9487-43CC-B885-8A381561A124Q31169310-8878BD13-D842-4DD8-B8BA-F0BF42EA3761Q33688526-EC28BADB-585F-4355-9988-5640DCAD3D3CQ33788094-FBABE789-825D-4987-AF80-6992BFD54A8EQ33815803-E7730CD8-83E8-46AA-9D6A-9B07DA40F251Q33980021-8C4A01F1-7483-40A8-8CD8-99AD9B3B7E2FQ34161839-1FF4D535-A9FD-4933-AEB9-F3B1845E7CC7Q34171651-BD71C845-C0BB-4892-9C13-135AC4956454Q34443423-1F9B00E7-1437-4425-82FC-3C7C237B457FQ34540211-C394CDF3-8681-4A85-BE5C-0FE0B340B090Q35627041-781254ED-EB8B-41F1-9FE9-43C11F437380Q35678578-3D5937DD-831A-4467-8E60-77400D0A4DE2Q35912396-1CED58B0-5230-4C58-A927-7A997E2637F5Q36071892-78A64EC6-04F3-4C3E-A9E3-8566685A7332Q36190707-88D20308-04C6-4AF6-8C61-650BF7B94DCFQ36284603-30E394B1-DFD4-46B8-BC1D-B46283775058Q36970184-8138839E-EC03-4ACB-BCC8-C20620BA8DF1Q37298050-821EB74F-7BC0-4DB1-AAAB-1217B5DBED36Q37406034-070CA8C4-79D5-4F88-BC44-D4942A7736A0Q37505555-239D18FC-A52E-42FE-B6E7-92915110586BQ37984496-5D4E0382-40CB-4CCF-AFE6-D27E7A4A87FAQ39052051-B078BB95-B75C-432E-8AD7-420A759B47D3Q39245566-B0F24DB0-9CC8-455A-9982-77B626CC932DQ39698908-BBBB371A-4245-4BD5-A0CB-BD04C4BB60F1Q40073901-D4596BE4-7C0C-47D5-9C94-2746292B9FCAQ46558019-398943EE-6268-4B86-B288-C46D9147C73AQ48023771-2BB07F0F-79D1-40AA-A49B-E1210D78807FQ53819699-BB199F94-5FEA-49DC-AF54-B74F250BA3A9
P2860
Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Using an improved phagocytosis ...... pregnancy-associated malaria.
@ast
Using an improved phagocytosis ...... pregnancy-associated malaria.
@en
type
label
Using an improved phagocytosis ...... pregnancy-associated malaria.
@ast
Using an improved phagocytosis ...... pregnancy-associated malaria.
@en
prefLabel
Using an improved phagocytosis ...... pregnancy-associated malaria.
@ast
Using an improved phagocytosis ...... pregnancy-associated malaria.
@en
P2860
P50
P921
P1433
P1476
Using an improved phagocytosis ...... pregnancy-associated malaria.
@en
P2093
Victor Mwapasa
Wina Hasang
P2860
P304
P356
10.1371/JOURNAL.PONE.0010807
P407
P577
2010-05-25T00:00:00Z